RNA sequencing has emerged as a powerful supplement to DNA sequencing for Mendelian disease diagnosis, but clinical translation of diagnostic RNA-seq has not been widely achieved. Researchers at ...

The MarketWatch News Department was not involved in the creation of this content. First-of-its-kind 1,000-patient clinical study will use RNA-based stool and saliva tests to detect colon polyps -- ...

Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in accelerating the impact of fundamental research on human health, today ...

Milestone highlights growing adoption of DNA and RNA-informed diagnostics for hereditary cancer and rare disease Ambry Genetics first implemented RNA testing in 2016 as part of a research and ...

The SARS-CoV-2 pandemic has created a rapid rise in demand for population and individual viral RNA sample testing. With most testing infrastructure depending on specialized instruments, their ...

Dr. Kayvan Zainabadi (center) is working with colleagues in Pune, India, to test the RNA-based TB diagnostic he is developing. From left: Dr. Mandar Paradkar (co-PI, pediatrician), Vidyulata Kamble, ...

Cancer is most treatable in its early stages, so finding innovative and non-invasive methods to diagnose cancer early on is crucial for fighting the disease. Liquid biopsies, which require just a ...

A laboratory test — or assay — developed in Sudbury, Ont., to measure the effectiveness of chemotherapy is one step closer to becoming commercially available. The Veridapt DX test, developed by Rna ...

In a development that could accelerate the discovery of new diagnostics and treatments, researchers have developed a versatile and low-cost technology for targeted sequencing of full-length RNA ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, a leader in clinical diagnostic testing and a subsidiary of REALM IDx, Inc., announced today the findings of a study that showed paired RNA and ...

Study aims to enhance colorectal cancer prevention by identifying polyp molecular signals, offering improved sensitivity over at-home DNA tests, which have limited ability to detect precancerous ...